One Care of Southwest Virginia offers

Educational Forum on Prescription Drug Abuse

Chesterfield, VA

Agenda

Activity Director: Sarah T. Melton, PharmD, BCPP, BCACP,FASCP

Associate Professor of Pharmacy Practice

Gatton College of Pharmacy at East Tennessee State University

September 11, 2016

Schedule / Topic / Learning Objectives
7:30 AM – 8:00 AM / Breakfast and Registration
8:00 AM – 8:15 AM / Welcome and Introductions
8:15 AM – 9:15 AM / REVIVE! Naloxone Training
Sarah Melton, PharmD / ·  Describe the REVIVE! program, including lay administration of naloxone, protection from civil liability, and the safe reporting of overdoses law.
·  Discuss how opioid overdose emergencies happen and how to recognize them.
·  Describe the mechanism of action of naloxone.
·  Identify risk factors that may make someone more susceptible to an opioid overdose emergency.
·  Respond to an opioid overdose emergency with the administration of naloxone.
9:15 AM – 10:15 AM / Disciplinary Actions from State Regulatory Boards
Hughes Melton, MD / ·  Discuss the reporting requirements for licensees who suspect their colleagues may be improperly prescribing.
·  Describe licensing boards' required approaches to pain management.
·  Explain how to update internal office policies and protocols to avoid disciplinary hearings.
10:15 AM – 10:30 AM / BREAK
10:30 AM – 11:30 AM / Safe Opioid Prescribing
Mary McMasters, MD FASAM
Co-Medical Director, Project REMOTE
Comprehensive Behavioral Health, Fishersville, VA / ·  Define addiction, substance misuse, tolerance, withdrawal, and physical dependence.
·  Understand addiction as a chronic relapsing brain disease.
·  Understand that there is evidence-based medical information on how to treat the disease.
·  Understand how to prescribe opioids as safely as possible.
11:30 AM – 12:30 AM / Overview of Outpatient Management of Opioid Dependence:Safety and Efficacy ofBuprenorphine and Methadone
Sarah T. Melton, PharmD, BCPP, BCACP,,FASCP
Associate Professor of Pharmacy Practice
Gatton College of Pharmacy at East Tennessee State University / •  Explain the rationale and effectiveness of buprenorphine and methadone maintenance therapy in the outpatient treatment of opioid dependence.
•  Contrast the safety profiles of buprenorphine and methadone used in the treatment of opiate dependence.
•  Describe the components and role of non-pharmacological treatments for opioid dependence.
•  Apply clinical tools (e.g., treatment agreements, urine drug screens, pill counts, etc.) needed for an effective outpatient treatment program.
12:30 PM – 1:15 PM / LUNCH
1:15 AM – 2:15 PM / Prescription Monitoring Program (PMP): Your Partner in Patient Management with Controlled Substances
Ralph Orr
Program Director
OR
Carolyn McKann, Deputy Director
Prescription Monitoring Program
Department of Health Professions
Richmond, VA / ·  Review the history of the development, initiation and utilization of the PMP in Virginia.
·  Explain the goals of the PMP.
·  Demonstrate how to use the PMP as a resource in patient-centered care.
2:15 PM– 3:15 PM / Universal Precautions in Prescribing Controlled Substances
Hughes Melton, MD / ·  Describe strategies prescribers and pharmacists can implement to minimize the risk of opioid misuse, abuse, and diversion.
·  Discuss red flags and warning signs of patients who intend to use or distribute opioids for nonmedical purposes.
·  Apply appropriate prescribing of controlled substances in clinical practice based on the CDC Prescribing Guidelines.
3:15 PM– 3:30 PM / Wrap Up and Evaluation